42 results about "Reducing anxiety" patented technology

The invention discloses lactobacillus reuteri CCFM1288 for relieving depressive mood and application of the lactobacillus reuteri CCFM1288, and belongs to the technical field of microorganisms. The lactobacillus reuteri CCFM1288 has the tryptophan metabolism capability, and can survive for 7 days in the intestinal tract; after the lactobacillus reuteri CCFM1288 intervenes a depressive mouse, anxiety-like and depression-like behaviors of the mouse can be obviously relieved, flora alpha-diversity is improved, intestinal symbiotic bacteria are promoted to secrete indole substances, intestinal homeostasis is maintained, hypothalamic-pituitary-adrenal axis hyperfunction is relieved, dopamine and serotonin neurotransmitter nervous system functions are improved, and the effect of preventing and treating depression is achieved. The neurotransmitter release is promoted, and the anti-depression effect is achieved. In clinical tests, intervention of Lactobacillus reuteri CCFM1288 can significantly improve the depressive symptom of MDD patients, and a new safe alleviation approach is provided for depression treatment.

Methods, systems and devices for reducing anxiety, including increasing relaxation and / or calm. In some variations these methods may include reducing anxiety, increase relaxation and / or calm by non-invasive temperature regulation of the frontal cortex prior to and / or during sleep. The subject may have an anxiety disorder, or may not have a diagnosed anxiety disorder.

The invention relates to Ackermann muciniphile as well as a regulator and application thereof, and relates to the technical field of biochemistry. The invention provides application of ackermann muciniphile in preparation of drugs for treating anxiety, and the ackermann muciniphile can significantly improve exploration interest, significantly reduce anxiety level and reverse anxiety manifestation caused by chronic stress, which indicates that the ackermann muciniphile has an effect of treating anxiety. The invention also provides an application of the regulator in preparation of medicines or health-care foods for regulating intestinal flora. The regulator comprises cape jasmine and fermented soybean soup. The regulator can obviously increase the quantity of Ackerman muciniphile in the intestinal tract of a mouse, so that the intestinal health is improved, and the micro-ecological balance of the intestinal tract of a human body is regulated.

The invention discloses application of Trolox in preparation of a medicine for treating autism, and belongs to the technical field of biological medicine. The invention finds that Trolox has the effect of preventing and / or treating autism for the first time, and further, animal experiments prove that Trolox prevents and / or treats autism by relieving repeated engraving behaviors of autism rats, rescuing social novelty disorders of the autism rats and reducing anxiety behaviors of the autism rats. The invention provides a theoretical basis and a new drug source for prevention and / or treatment of autism.

An animal garment comprises a central portion having a longitudinal axis and including a front end, and a rear end opposite the front end, a first side extending laterally in a first direction from the longitudinal axis, the first side including a free distal end, and a second side extending laterally in a second direction from the longitudinal axis, the second side including a free distal end. When worn, the first side and the second side are configured to extend around the mid-body of the animal and fasten to each other forming a shape conforming to the outside of the mid-body of the animal. The front end of the central portion is positioned proximate to the head of the animal. The garment applies pressure to the animal adequate to reduce anxiety, fearfulness, overexcitement, or a combination thereof in the animal.

In alternative embodiments, provided are products of manufacture, including devices and integrated systems, and methods, for reducing error-related negativity (ERN) and anxiety, and for treating or ameliorating Anxiety Disorders such as Generalized Anxiety Disorder (GAD) or Social Anxiety Disorder (SAD) and obsessive-compulsive disorder (OCD).

This invention discloses a sleep-aid composition that synergistically regulates sleep rhythm with 5-HTP and L-theanine, relating to the fields of biomedicine and health food technology. This invention effectively regulates sleep rhythm through the synergistic effect of 5-hydroxytryptophan, L-theanine, and γ-aminobutyric acid (GABA), helping users improve sleep quality. 5-HTP, as a precursor to serotonin, helps increase serotonin levels, which are then converted into melatonin, regulating the sleep cycle. L-theanine promotes the release of alpha brain waves, helping to relax the mind and body and reduce anxiety. GABA, as an inhibitory neurotransmitter, effectively relieves tension and promotes deep sleep. The synergistic effect of these three components provides users with more comprehensive and effective sleep support.

The invention provides psychology attention training equipment, and belongs to the technical field of psychology teaching. Comprising a supporting assembly, a box body assembly is arranged at the upper end of the supporting assembly, a notch is formed in the middle of the front end of the box body assembly, the transverse diameter and the longitudinal diameter of the notch are matched with the transverse diameter and the longitudinal diameter of a displacement assembly, and a mounting assembly is arranged at the upper end of the box body assembly. The I-shaped base, the frame, the square frame and the top box are arranged and spliced into a small compartment with only one entrance and exit, meanwhile, the small compartment is closed in cooperation with the L-shaped frame, follow-up training is conducted in the small compartment, a relatively-closed personal space is provided for students and children who leave the familiar environment and have social terrorism and self-closing, and therefore the students and children can carry out training conveniently and rapidly. According to the invention, interference of an external environment is reduced, a self-adjusting space is reserved, and an obvious social avoidance demand is met, so that the people can relax the mind more easily and reduce anxiety and nervous mood, and thus the people can concentrate on attention deficit training.

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for improving mood in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

To provide means for reducing anxiety toward AI and deepening understanding of AI.SOLUTION: A system comprises: a device equipped with an AI assistant that can have a conversation; means for deepening understanding of AI through casual conversation with the AI assistant; and means for reducing anxiety.SELECTED DRAWING: Figure 1

The application provides an application of an NEDD8 inhibitor in preparation of anxiolytic drugs. The application proves through experiments that inhibition of NEDD8 by means of gene editing or inhibition of NEDD8 by a compound can exert an anxiolytic effect. The NEDD8 inhibitor can reduce inflammatory activation of microglia and reduce anxiety, and provides a new strategy for research and development of anxiolytic drugs.

The invention provides an emotion support art treatment platform for depression patients, which comprises a patient residence, and a medicine supply device, an art platform and a control system arranged in the patient residence, and the control system comprises a computer of a networked medical institution terminal in the residence. The cloud server is networked with a medical institution terminal or an intelligent mobile terminal held by a physician, and the medicine supply device is controlled by the control system and intervenes medicine in a water source or food so that patients can drink or eat the medicine respectively. According to the treatment platform, drug supply and mental support are integrated depending on the residence of the patient, the patient is prevented from being reminded of the behavior of the pregnant woman to realize the illness condition of the pregnant woman in the diet aspect through regular door-to-door drug supplement of the medical institution and the technical performance personnel, anxiety is reduced, and communication is performed in an art performance form while door-to-door. And dual treatment from pharmacology and psychology is realized.

The present invention discloses a sleep-aid composition for synergistically regulating the sleep rhythm with 5-HTP and L-theanine, relating to the technical field of biomedicine and health foods. Through the synergistic action of 5-hydroxytryptophan, L-theanine, and gamma-aminobutyric acid, the present invention effectively regulates the sleep rhythm and helps users improve sleep quality. As a precursor of serotonin, 5-HTP helps increase the serotonin level and is then converted into melatonin to regulate the sleep cycle. L-theanine promotes the release of alpha brain waves to help relax the body and mind and reduce anxiety. As an inhibitory neurotransmitter, GABA can effectively relieve tension and promote deep sleep. The three components act synergistically to provide users with more comprehensive and more effective sleep support.

The present application relates to the fields of medicine, health care products and food technology, and in particular to a traditional Chinese medicine composition for mood and cognitive impairment caused by degenerative diseases, which is made of the following raw materials by weight: 1-35 parts of radix puerariae, 1-35 parts of semen ziziphi spinosae, 1-35 parts of radix bupleuri, 1-35 parts of clematis, 1-35 parts of radix astragali, and 1-35 parts of herba eriodes. The present application has the effects of preventing and treating mood and cognitive impairment caused by various degenerative diseases, reducing anxiety-like response and depression level caused by degenerative diseases, preventing overexcitability of the nervous system, significantly improving learning and cognitive ability, and having stable effects without inhibiting normal nerve activity and hormone level.

This invention provides an application of the combined use of rhizoma sarcodactylis and ginsenosides in the prevention and / or treatment of neuropsychiatric disorders, relating to the field of biomedical technology. The combined use of rhizoma sarcodactylis and ginsenosides demonstrates significant effects in improving symptoms of post-traumatic stress disorder (PTSD) and depression, exhibiting a synergistic effect. It effectively alleviates invasive symptoms caused by post-traumatic stress events; reduces fear-avoidance of trauma-related stimuli in mice; effectively improves hypervigilance states such as arousal and sleep disturbances; significantly reduces anxiety levels in stressed mice; reverses stress-induced anhedonia; not only fades traumatic memories but also protects and improves normal neutral memory function; and for depression, it effectively reduces anxiety-like and depression-like behaviors in depressed model mice, overcoming the memory generalization problem that may arise from traditional treatments.

The invention provides an active peptide composition for regulating emotion and improving side effects of drugs, and relates to the technical field of active peptide compositions. The active peptide composition provided by the invention comprises an emotion regulating component and a nerve recovery promoting component, the emotion regulating component comprises theanine, gamma-aminobutyric acid (GABA), a perilla leaf extract, nano curcumin and a black pepper extract, and the components have a synergistic effect to jointly inhibit depression and central nervous system hyperexcitation and regulate emotion; the nerve recovery promoting component comprises N-acetylneuraminic acid, phosphatidylserine, brain peptide VVAVP and a perilla leaf extract, and the components cooperate with one another, so that brain recovery is promoted, anxiety is reduced, and memory is improved; the emotion regulating component and the nerve recovery promoting component cooperate with each other, the dosage of the components is optimized, depression and central nervous hyperexcitation are jointly inhibited, emotion is regulated, brain recovery is promoted, anxiety is reduced, memory is improved, the digestion and absorption effects are good, and burden on intestines and stomach is small.

Methods, systems and devices for reducing anxiety, including increasing relaxation and / or calm. In some variations these methods may include reducing anxiety, increasing relaxation and / or calm by non-invasive temperature regulation of the frontal cortex prior to and / or during sleep. The subject may have an anxiety disorder, or may not have a diagnosed anxiety disorder.

A composition for immunomodulation and a corresponding method. The composition comprises an emulsion formed by mixing a pharmaceutically acceptable carrier and an active component. The pharmaceutically acceptable carrier accounts for 15 wt% to 85 wt% of the composition. The active ingredients include an effective amount of a cannabis extract to provide a source of exogenous cannabinoids, an effective amount of a cannabinoid enhancer to inhibit cannabinoid hydrolase, an effective amount of a fatty acid amide to enhance cannabinoid activity through an accompanying effect, an effective amount of a piper nigrum extract to alleviate anxiety and an effective amount of an alkaloid to enhance the bioavailability of one or more of the active ingredients.

The present invention relates to a system and a method for creating a simulated environment for a subject undergoing and waking up from anesthesia. The system comprises a stimulation module (12), a subject monitoring module (14), and a controller (16). The stimulation module (12) comprises one or more sensory stimulation devices configured to apply at least one sensory stimulus over a subject to simulate an environment that will be experienced by the subject undergoing and waking up from anesthesia. The subject monitoring module (14) comprises one or more sensors configured to acquire sensor data from the subject. The controller (16) is configured to determine a sedation state of the subject based on the acquired sensor data and to control at least one of the one or more sensory simulation devices to modify the simulated environment based on the sedation state of the subject. The system may be used to create an ambient experience for a gentle transition into and / or from anesthesia. For example, the system may create an adaptive elements in the story to prevent or reduce the subject's mental confusion, thereby increasing temporal structure, so that the risk for getting delirium becomes smaller. In addition, the system may reduce anxiety upon the waking up. Furthermore, by reducing the subject's mental confusion and anxiety, the length of stay in the hospital may also be reduced.

A method of reducing anxiety in a subject. In some embodiments, the method includes the steps of: providing an audio input to the subject, the audio input including a sequence of tones in a frequency range comprising about 100 Hz to about 8000 Hz and having intensities adapted to audiometric parameters of the subject; producing a plurality of actuation signals correlated with the audio input; delivering an actuation signal of the plurality of actuation signals to each of a plurality of electrodes in contact with a tissue surface of the subject's body to provide tactile stimuli to the tissue surface; and reducing anxiety in the subject.

The invention discloses a nursing and rehabilitation bed for old people, and relates to the technical field of medical instruments, the nursing and rehabilitation bed comprises a bed body and guardrails, the left side and the right side of the bed body are each provided with two bandages, and a first protection mechanism used for preventing the bandage from being pulled too fast is arranged between the end of each bandage and the bed body. The bandages are suspended above the guardrails and are not in direct contact with the body of the patient, so that the body of the patient can freely move on the bed in a small range, the patient is not bound, the comfort is better, the anxiety and fear of the patient are reduced, and the dignity of the patient is also maintained; when the patient may face risks at night, automatic alarm is set to notify nursing personnel in time, and double alarm modes are combined, so that the occurrence of missing alarm is avoided, and the safety of the patient at night is improved; and meanwhile, the psychological pressure of the guardian is relieved. The medical nursing bed is scientific and reasonable in structural design and easy and convenient to use, and the problems that an existing nursing bed for the old is too large in limiting range, patient autonomy and too low in freedom degree can be effectively solved.

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for reducing anxiety in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for improving energy in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

The invention provides genistein compound essential oil as well as a preparation method and application thereof, and the genistein compound essential oil comprises the following components in parts by mass: 40%-45% of genistein essential oil, 5%-10% of laurel essential oil, 5%-10% of salvia officinalis, 5%-10% of lavender oil, 5%-8% of sweet orange essential oil, 5%-10% of jasmine essential oil and 5%-8% of vetiver (frankincense) essential oil. And adding the basic carrier oil to 100%. The product disclosed by the invention is applied to aromatherapy and aromatherapy products. The natural genistein compound essential oil provided by the invention is beneficial to improving mood and increasing pleasure and happiness by virtue of the fresh wood fragrance, and for climacteric women, the natural genistein compound essential oil is possibly beneficial to relieving depression and low mood, and relieving anxiety and tension; meanwhile, the dye wood essential oil has relaxing and calming effects and is used for improving the sleep quality of women.

Embodiments herein relate to identifying a status of a patient such as in a dental or other medical treatment room. In one aspect, the solutions provide a system to determine whether the patient is anxious and / or a degree of anxiety of the patient. The solutions can include training a model such as a large language model (LLM). In a training phase, data is gathered from patients, the environments of treatment rooms and equipment of the treatment rooms during various medical procedures for a patient population. The model is then trained to correlate the data with a degree of anxiety. Once the model is trained, it can be deployed to determine whether an individual patient is anxious and to take appropriate countermeasures to reduce anxiety.

Disclosed herein are formulations of cannabidiol (CBD) and terpenes that increase restorative sleep and reduce anxiety and depression in humans.

[0003] Methods and apparatuses for reducing anxiety using mixed reality are disclosed herein. An exemplary method for reducing anxiety in a person during a blood draw procedure includes providing a mixed reality headset to the person before collecting blood from the person. The method includes initiating a mixed reality program on the mixed reality headset. The mixed reality program causes a display device to display a mixed reality environment having one or more virtual objects on glasses of the headset, determines a gaze direction of the person's eyes, and causes a change in one or more of the virtual objects in the mixed reality environment based on the gaze direction. The method further includes collecting blood from the person while the person is exposed to the mixed reality program.

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for reducing food cravings in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

The present invention relates to a system and a method for creating a simulated environment for a subject undergoing and waking up from anesthesia. The system comprises a stimulation module (12), a subject monitoring module (14), and a controller (16). The stimulation module (12) comprises one or more sensory stimulation devices configured to apply at least one sensory stimulus over a subject to simulate an environment that will be experienced by the subject undergoing and waking up from anesthesia. The subject monitoring module (14) comprises one or more sensors configured to acquire sensor data from the subject. The controller (16) is configured to determine a sedation state of the subject based on the acquired sensor data and to control at least one of the one or more sensory simulation devices to modify the simulated environment based on the sedation state of the subject. The system may be used to create an ambient experience for a gentle transition into and / or from anesthesia. For example, the system may create an adaptive elements in the story to prevent or reduce the subject's mental confusion, thereby increasing temporal structure, so that the risk for getting delirium becomes smaller. In addition, the system may reduce anxiety upon the waking up. Furthermore, by reducing the subject's mental confusion and anxiety, the length of stay in the hospital may also be reduced.

A computer system and method for use in connection with patient anxiety / pain mitigation during dental and other healthcare procedures. A menu of content objects representative of extended reality anxiety / pain mitigation-related content material can be provided to a patient by a user interface. In response to requests for the content material via user selection of the content objects from the menu, the requested content material is retrieved and provided for by an advanced AI presentation system to the patient via an extended reality hardware component. An artificial intelligence model trained on patient data and associated content material selections from a plurality of previous healthcare encounters can be used to provide recommendations for the content material. The user interface includes a chatbot system with an empathetic conversational avatar.